Catalyzing Social Support for Breast Cancer Patients

Genomic assays. Unlike individual gene testing, such as testing for HER2, genomic assays analyze the activity of a group of normal and abnormal genes that can increase the risk of breast cancer coming back after treatment. This analysis can help decide if a person is likely to benefit from chemotherapy to reduce the risk of the cancer coming back. Two types of genomic assays for breast cancer are currently in use: Oncotype DX and MammaPrint. If the breast cancer is early-stage and hormone-receptor-positive, you and your doctor may decide that a genomic assay is appropriate for your situation. The...